From USFDA
Zydus Cadila has received the final approval from the USFDA to market Ziprasidone Hydrochloride Capsules in strengths of 20mg, 40mg, 60mg and 80mg. Ziprasidone, an antipsychotic medication, is used to treat schizophrenia and the manic symptoms of bipolar disorder.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)